Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Displacement of BODIPY 500/510 C4 from human FABP3 expressed in Escherichia coli incubated for 30 mins by FP assay
Assay data:4 Active, 1 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to human FABP3 expressed in Escherichia coli assessed as degree of fluorescent shift by temperature-dependent fluorescence thermal shift assay
Assay data:2 Active, 2 Activity ≤ 1 µM, 4 Tested
Inhibition of FABP5 (unknown origin)
Assay data:11 Active, 8 Activity ≤ 1 µM, 14 Tested
Inhibition of human FABP5
Assay data:6 Active, 5 Activity ≤ 1 µM, 6 Tested
Inhibition of recombinant human FABP3
Assay data:5 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of FABP5 (unknown origin) by fluorescence polarization assay
Assay data:4 Active, 6 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of FABP3 (unknown origin) by fluorescence polarization assay
Assay data:4 Active, 1 Activity ≤ 1 µM, 5 Tested
Inhibition of FABP3 (unknown origin) assessed as inhibition constant
Assay data:4 Active, 3 Activity ≤ 1 µM, 4 Tested
Inhibition of FABP5 (unknown origin) assessed as inhibition constant
Assay data:3 Active, 1 Activity ≤ 1 µM, 4 Tested
FABP3, FABP5, and FABP7 Binding Assay from US Patent US20230365488: "TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF"
Assay data:47 Active, 22 Activity ≤ 1 µM, 47 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Assay data:1 Tested
High Throughput Fluorescence Displacement Assay from US Patent US10968163: "Alpha-truxillic acid derivatives and pharmaceutical compositions thereof"
Assay data:34 Active, 33 Activity ≤ 1 µM, 34 Tested
Fluorescent Displacement Assay from US Patent US10709688: "Agent for treating synucleinopathy"
Assay data:16 Active, 10 Activity ≤ 1 µM, 16 Tested
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9353102: "Non-annulated thiophenylamides"
Assay data:42 Active, 40 Activity ≤ 1 µM, 42 Tested
Ligand Binding Assay from Article 10.1074/jbc.M113.514646: "Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor /d (FABP5-PPAR /d) signaling pathway."
Assay data:6 Active, 2 Activity ≤ 1 µM, 6 Tested
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9278918: "Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors"
Assay data:16 Active, 14 Activity ≤ 1 µM, 16 Tested
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9604977: "Bicyclic thiophenylamide compounds"
Assay data:251 Active, 212 Activity ≤ 1 µM, 251 Tested
Binding affinity to FABP5 (unknown origin) by microscale thermophoresis analysis
Assay data:3 Tested
Displacement of 1,8-ANS from FABP3 (unknown origin) incubated for 3 mins by fluorescence based analysis
Assay data:1 Active, 5 Tested
Displacement of 1,8-ANS from FABP5 (unknown origin) incubated for 3 mins by fluorescence based analysis
Assay data:11 Active, 30 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on